## Background: Hemoglobin increases have been associated with quality of life (qol) improvements in anemic cancer patients treated with epoetin alfa, but intervention generally has been reserved for symptomatic anemia or hemoglobin < 10 g/dl. relationships among hemoglobin, functional status, and p
β¦ LIBER β¦
Development of a fatigue and functional impact scale in anemic cancer patients receiving chemotherapy
β Scribed by David Cella; Hema N. Viswanathan; Ron D. Hays; Tito R. Mendoza; Kevin D. Stein; David J. Pasta; Aimee J. Foreman; Saroj Vadhan-Raj; Joel D. Kallich
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 109 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Relationship between changes in hemoglob
β
Jeffrey Crawford; David Cella; Charles S. Cleeland; Pierre-Yves Cremieux; George
π
Article
π
2002
π
John Wiley and Sons
π
English
β 99 KB
π 1 views
Relationship between changes in hemoglob
β
Anders Γsterborg; Yvonne Brandberg
π
Article
π
2003
π
John Wiley and Sons
π
English
β 67 KB
π 1 views
## Abstract DOI 10.1002/cncr.11430
Predicting individual risk of neutropeni
β
Gary H. Lyman; Nicole M. Kuderer; Jeffrey Crawford; Debra A. Wolff; Eva Culakova
π
Article
π
2010
π
John Wiley and Sons
π
English
β 399 KB
π 1 views
Development of Quality of Life Questionn
β
Minoru Kurihara; Hiroyuki Shimizu; Koji Tsuboi; Kunihiko Kobayashi; Minoru Murak
π
Article
π
1999
π
John Wiley and Sons
π
English
β 97 KB
π 2 views
Accuracy of clinical evaluation of local
β
Raquel Prati; Christina A. Minami; Jeff A. Gornbein; Nanette Debruhl; Debbie Chu
π
Article
π
2009
π
John Wiley and Sons
π
English
β 128 KB
Once-weekly dosing of epoetin-Ξ± increase
β
Daniel Shasha; Martine J. George; Louis B. Harrison
π
Article
π
2003
π
John Wiley and Sons
π
English
β 114 KB
## Abstract ## BACKGROUND The current study was performed to prospectively evaluate the effectiveness, clinical outcomes, and safety of onceβweekly (QW) recombinant human erythropoietin (rβHuEPO [epoetinβΞ±]) in anemic cancer patients with nonmyeloid malignancies who were receiving radiation therap